All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV-TB Coinfection-31117863

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	31117863	A62V	RT	gag-pol	HIV-TB Coinfection	D G R	View
2	31117863	A98G	RT	gag-pol	HIV-TB Coinfection	D G R	View
3	31117863	D67E	RT	gag-pol	HIV-TB Coinfection	D G R	View
4	31117863	D67N	RT	gag-pol	HIV-TB Coinfection	D G R	View
5	31117863	E138K	RT	gag-pol	HIV-TB Coinfection	D G R	View
6	31117863	E44D	RT	gag-pol	HIV-TB Coinfection	D G R	View
7	31117863	F116Y	RT	gag-pol	HIV-TB Coinfection	D G R	View
8	31117863	F227L	RT	gag-pol	HIV-TB Coinfection	D G R	View
9	31117863	G190A	RT	gag-pol	HIV-TB Coinfection	D G R	View
10	31117863	G190E	RT	gag-pol	HIV-TB Coinfection	D G R	View
11	31117863	G190S	RT	gag-pol	HIV-TB Coinfection	D G R	View
12	31117863	G48M	PR	gag-pol	HIV-TB Coinfection	D G R	View
13	31117863	K101E	RT	gag-pol	HIV-TB Coinfection	D G R	View
14	31117863	K101Q	RT	gag-pol	HIV-TB Coinfection	D G R	View
15	31117863	K103N	RT	gag-pol	HIV-TB Coinfection	D G R	View
16	31117863	K103R	RT	gag-pol	HIV-TB Coinfection	D G R	View
17	31117863	K103S	RT	gag-pol	HIV-TB Coinfection	D G R	View
18	31117863	K219E	RT	gag-pol	HIV-TB Coinfection	D G R	View
19	31117863	K219N	RT	gag-pol	HIV-TB Coinfection	D G R	View
20	31117863	K219Q	RT	gag-pol	HIV-TB Coinfection	D G R	View
21	31117863	K238T	RT	gag-pol	HIV-TB Coinfection	D G R	View
22	31117863	K65R	RT	gag-pol	HIV-TB Coinfection	D G R	View
23	31117863	K70R	RT	gag-pol	HIV-TB Coinfection	D G R	View
24	31117863	L210W	RT	gag-pol	HIV-TB Coinfection	D G R	View
25	31117863	L74I	RT	gag-pol	HIV-TB Coinfection	D G R	View
26	31117863	L74V	RT	gag-pol	HIV-TB Coinfection	D G R	View
27	31117863	M184V	RT	gag-pol	HIV-TB Coinfection	D G R	View
28	31117863	M41L	RT	gag-pol	HIV-TB Coinfection	D G R	View
29	31117863	M46I	PR	gag-pol	HIV-TB Coinfection	D G R	View
30	31117863	Q151M	RT	gag-pol	HIV-TB Coinfection	D G R	View
31	31117863	T215F	RT	gag-pol	HIV-TB Coinfection	D G R	View
32	31117863	T215S	RT	gag-pol	HIV-TB Coinfection	D G R	View
33	31117863	T215V	RT	gag-pol	HIV-TB Coinfection	D G R	View
34	31117863	T215Y	RT	gag-pol	HIV-TB Coinfection	D G R	View
35	31117863	T69D	RT	gag-pol	HIV-TB Coinfection	D G R	View
36	31117863	T69N	RT	gag-pol	HIV-TB Coinfection	D G R	View
37	31117863	T74S	PR	gag-pol	HIV-TB Coinfection	D G R	View
38	31117863	V106M	RT	gag-pol	HIV-TB Coinfection	D G R	View
39	31117863	V108I	RT	gag-pol	HIV-TB Coinfection	D G R	View
40	31117863	V118I	RT	gag-pol	HIV-TB Coinfection	D G R	View
41	31117863	V179D	RT	gag-pol	HIV-TB Coinfection	D G R	View
42	31117863	V75A	RT	gag-pol	HIV-TB Coinfection	D G R	View
43	31117863	V75I	RT	gag-pol	HIV-TB Coinfection	D G R	View
44	31117863	V75M	RT	gag-pol	HIV-TB Coinfection	D G R	View
45	31117863	Y115F	RT	gag-pol	HIV-TB Coinfection	D G R	View
46	31117863	Y181C	RT	gag-pol	HIV-TB Coinfection	D G R	View
47	31117863	Y181I	RT	gag-pol	HIV-TB Coinfection	D G R	View
48	31117863	Y181V	RT	gag-pol	HIV-TB Coinfection	D G R	View
49	31117863	Y188C	RT	gag-pol	HIV-TB Coinfection	D G R	View
50	31117863	Y188L	RT	gag-pol	HIV-TB Coinfection	D G R	View
51	31117863	Y318F	RT	gag-pol	HIV-TB Coinfection	D G R	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.